We invite others to join us in delivering meaningful improvements in health outcomes and long-term economic value." The Impact of GLP-1s: Health Improves, Cost Curve Bends To help companies quantify the opportunity and impact of GLP-1 coverage, Aon leveraged a proprietary methodology and the firm's Health Risk Analyzer to evaluate an extensive dataset of medical and Rx claims data from over 50 million commercially insured lives, including 139,000 prescribed GLP-1 users from 2022-2024
Evidence from clinical trials Related Stories Experts urge Mexico to integrate liver disease into chronic care Study tests chronotypes liver link and finds no significant association Targeting CMPK2-intervened redox metabolism to mitigate hepatic ischemia-reperfusion injury Several GLP-1RAs, including liraglutide, semaglutide, and tirzepatide, have been evaluated in clinical trials for their efficacy in the management of MASLD
In another phase 2 trial of obese patients with type 2 diabetes, the combination of cagrilintide 2.4 mg/week and the GLP-1R semaglutide 2.4 mg/week (referred to as CagriSema) was compared with each drug alone
Reference: Sikiric P et al
This may be due to cultural expectations, chronic stress, caregiving roles, hormonal shifts, and decades of diet culture messaging that equates worth with control and thinness
